HR Execs on the Move

Bayer

www.bayer.us

 
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Our products are helping to address some of today`s biggest challenges, including global population growth, an aging society and the need to make efficient – and, wherever possible, sustainable – use of natural resources. We are improving people`s quality of life by preventing, alleviating or curing diseases. We are helping to provide an ...
  • Number of Employees: 50K-100K
  • Annual Revenue: > $1 Billion
  • www.bayer.us
  • 100 Bayer Boulevard
    Whippany, NJ USA 07981
  • Phone: +49 8624 043000

Executives

Name Title Contact Details
Rachel Koontz
VP R&D Allergy, Cough Cold, Pain & Cardio at Bayer Consumer Health Profile
David Caldwell
Head of Biologics Data Science, Biologics R&D, Bayer Crop Science Profile
David Townson
Executive, Oncology Research and Development : Immuno-Oncology, Cell Therapy Profile
Michelle Lamendola
Global R&D Director, Pipeline & Project Management Profile
Alexander Novak
Head of Laboratory – Process R&D Profile

Jobs

Director Human Resources

Bayer Berkeley, CA
YOUR TASKS AND RESPONSIBILITIES
The primary responsibilities of this role, as Director Human Resources, are to:
Pharma PS West Coast:

Provide leadership for global initiatives/processes and ensure
proper coordination between global and local;

Ensure the US perspective is clear at the global level and
partner in creating solutions;

Similar Companies

Validation Inc

Validation Inc is a Whitehall, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Tobira Therapeutics

Tobira Therapeutics is a clinical-stage biopharmaceutical company developing cenicriviroc (CVC), an oral potent dual inhibitor of chemokine receptors CCR2 and CCR5. Tobira is initiating a Phase 2 clinical trial of cenicriviroc for the treatment of Nonalcoholic Steatohepatitis (NASH), a leading cause of cirrhosis and liver transplant. The company has also completed a Phase 2b clinical trial of cenicriviroc in 143 HIV-infected subjects, and the compound is positioned for Phase 3 studies as a novel, once daily, fixed-dose cenicriviroc/lamivudine backbone as part of combination HIV therapy. Tobira is backed by a syndicate of leading life science investors including Domain Associates, Frazier Healthcare Ventures, Montreux Equity Partners, Novo Ventures and Canaan Partners.

US Micron

US Micron is a Lenexa, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Anuncia

Anuncia Medical, Inc., an emerging leader in Cerebrospinal Fluid (CSF) management